Positive Allosteric Modulation of the 5-HT1A Receptor by Indole-Based Synthetic Cannabinoids Abused by Humans
Hideaki Yano, Pramisha Adhikari, Sett Naing, Alexander F. Hoffman, Michael H. Baumann, Carl R. Lupica, Lei Shi
ACS Chemical Neuroscience April 23, 2020 DOI: 10.1021/acschemneuro.0c00034 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Mice lacking cannabinoid receptor 1, and neurons in vitro |
| Interventions | AM2201 JWH-018 |
| Keywords | Allosteric regulation Allosteric modulator Pharmacology Agonist Mechanism of action Cannabinoid receptor In vitro Biochemistry |
| Citations | 26 |
| Key findings | Indole-moiety containing synthetic cannabinoids AM2201 and JWH-018 act as positive allosteric modulators at the 5-HT1A receptor, potentiating its effects. |
Abstract
The nonmedical (i.e., recreational) misuse of synthetic cannabinoids (SCs) is a worldwide public health problem. When compared to cannabis, the misuse of SCs is associated with a higher incidence of serious adverse effects, suggesting the possible involvement of noncannabinoid sites of action. Here, we find that, unlike the phytocannabinoid Δ9-tetrahydrocannabinol, the indole-moiety containing SCs, AM2201 and JWH-018, act as positive allosteric modulators (PAMs) at the 5-HT1A receptor (5-HT1AR). This suggests that some biological effects of SCs might involve allosteric interactions with 5-HT1ARs. To test this hypothesis, we examined effects of AM2201 on 5-HT1AR agonist-activated G protein-coupled inwardly rectifying potassium channel currents in neurons in vitro and on the hypothermic response to 5-HT1AR stimulation in mice lacking the cannabinoid receptor 1. We found that both 5-HT1AR effects were potentiated by AM2201, suggesting that PAM activity at 5-HT1AR may represent a novel noncannabinoid receptor mechanism underlying the complex profile of effects for certain SCs.
Citations in the library
Cited by 4
- Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor ACS Chemical Neuroscience October 17, 2023
- 5‐HT 2A receptor agonism by tert ‐leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence British Journal of Pharmacology May 5, 2026
- The Synthetic Cannabinoids Eurasian Journal of Toxicology April 30, 2024
- Synthetic Cannabinoids: A Pharmacological and Toxicological Overview. The Annual Review of Pharmacology and Toxicology August 1, 2022
Cites 6
- Disruption of hippocampal synaptic transmission and long‐term potentiation by psychoactive synthetic cannabinoid ‘Spice’ compounds: comparison with Δ9‐tetrahydrocannabinol Addiction Biology January 5, 2016
- Repeated Exposure to the “Spice” Cannabinoid JWH-018 Induces Tolerance and Enhances Responsiveness to 5-HT1A Receptor Stimulation in Male Rats Frontiers in Psychiatry February 27, 2018
- The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins. Handbook of experimental pharmacology 2018
- Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats. Drug and Alcohol Dependence October 1, 2017
- Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids. Current Topics in Behavioral Neurosciences 2017
and 1 more in the library